Literature DB >> 16785351

Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction.

Lee R Goldberg1, Mariell Jessup.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785351     DOI: 10.1161/CIRCULATIONAHA.105.600437

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  35 in total

1.  Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy.

Authors:  Ali Yilmaz; Hans-Jürgen Gdynia; Matthias Ponfick; Sabine Rösch; Alfred Lindner; Albert C Ludolph; Udo Sechtem
Journal:  Clin Res Cardiol       Date:  2011-12-06       Impact factor: 5.460

2.  Gated SPECT: what's the ideal method to measure LVEF?

Authors:  Sum-Che Man; Ernst E van der Wall; Cees A Swenne
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-02       Impact factor: 2.357

3.  Relation of left ventricular mass at age 23 to 35 years to global left ventricular systolic function 20 years later (from the Coronary Artery Risk Development in Young Adults study).

Authors:  Satoru Kishi; Anderson C Armstrong; Samuel S Gidding; David R Jacobs; Stephen Sidney; Cora E Lewis; Pamela J Schreiner; Kiang Liu; João A C Lima
Journal:  Am J Cardiol       Date:  2013-10-04       Impact factor: 2.778

Review 4.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

Review 5.  Cardiomyopathy in Childhood Cancer Survivors: Lessons from the Past and Challenges for the Future.

Authors:  Matthew J Ehrhardt; Joy M Fulbright; Saro H Armenian
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

Review 6.  Cardio-oncology: protecting the heart from curative breast cancer treatment.

Authors:  Jenica N Upshaw
Journal:  Gland Surg       Date:  2018-08

7.  Racial differences in incident heart failure among young adults.

Authors:  Kirsten Bibbins-Domingo; Mark J Pletcher; Feng Lin; Eric Vittinghoff; Julius M Gardin; Alexander Arynchyn; Cora E Lewis; O Dale Williams; Stephen B Hulley
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

8.  Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.

Authors:  Ian J Neeland; Mark H Drazner; Jarett D Berry; Colby R Ayers; Christopher deFilippi; Stephen L Seliger; Vijay Nambi; Darren K McGuire; Torbjørn Omland; James A de Lemos
Journal:  J Am Coll Cardiol       Date:  2012-12-05       Impact factor: 24.094

9.  Relation of short-term heart rate variability to incident heart failure (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Sidharth A Shah; Thomas Kambur; Cheeling Chan; David M Herrington; Kiang Liu; Sanjiv J Shah
Journal:  Am J Cardiol       Date:  2013-05-16       Impact factor: 2.778

Review 10.  Beta-blocker use for the stages of heart failure.

Authors:  Marc Klapholz
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.